What researchers should watch for in REDEFINE 4 beyond the headline weight loss number includes several secondary outcomes
First-timers get a welcome text the same day
If you are currently taking medications, have existing health conditions, are pregnant or nursing, or are considering changes to your health regimen, consult your physician before starting any new supplement
Australia is estimated to post a 16.9% CAGR through telehealth acceptance across distant communities
These realities show that while GLP-1s help reduce weight, they rarely address the underlying metabolic factors that drive long-term weight gain
In Phase 3 studies: Participants without diabetes taking orforglipron lost approximately 9% to 10% of body weight over roughly 36 to 40 weeks Participants with type 2 diabetes generally lost around 7% to 8% By comparison, Wegovy's landmark STEP trials reported approximately 14.9% average weight loss over 68 weeks